Fortress Biotech, Inc.
FBIO
$2.72
$0.010.37%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 66.85M | 64.02M | 61.24M | 59.29M | 56.90M |
| Total Other Revenue | 1.62M | 2.14M | 2.02M | 3.01M | 2.40M |
| Total Revenue | 68.47M | 66.16M | 63.26M | 62.30M | 59.30M |
| Cost of Revenue | 24.74M | 30.86M | 32.83M | 42.38M | 50.33M |
| Gross Profit | 43.72M | 35.30M | 30.43M | 19.93M | 8.97M |
| SG&A Expenses | 68.85M | 86.80M | 96.57M | 108.70M | 113.28M |
| Depreciation & Amortization | 4.22M | 4.32M | 4.26M | 4.17M | 3.92M |
| Other Operating Expenses | -- | -- | -- | -4.55M | -4.55M |
| Total Operating Expenses | 97.81M | 121.97M | 133.65M | 150.70M | 162.98M |
| Operating Income | -29.35M | -55.81M | -70.39M | -88.39M | -103.68M |
| Income Before Tax | 145.86M | 133.28M | -33.71M | -53.47M | -88.95M |
| Income Tax Expenses | 4.66M | 4.34M | -790.00K | 362.00K | 405.00K |
| Earnings from Continuing Operations | 141.19 | 128.94 | -32.92 | -53.83 | -89.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -29.38M | -1.17M | 39.73M | 57.82M | 74.62M |
| Net Income | 111.82M | 127.77M | 6.82M | 3.99M | -14.73M |
| EBIT | -29.35M | -55.81M | -70.39M | -88.39M | -103.68M |
| EBITDA | -24.75M | -51.12M | -65.73M | -83.76M | -99.25M |
| EPS Basic | 3.29 | 3.86 | -0.05 | -0.22 | -1.12 |
| Normalized Basic EPS | 2.31 | 2.44 | 0.42 | 0.65 | 0.18 |
| EPS Diluted | 2.65 | 3.18 | -0.12 | -0.29 | -1.17 |
| Normalized Diluted EPS | 1.88 | 2.00 | 0.33 | 0.56 | 0.17 |
| Average Basic Shares Outstanding | 120.96M | 116.05M | 110.96M | 106.59M | 99.04M |
| Average Diluted Shares Outstanding | 133.69M | 131.72M | 119.76M | 115.39M | 101.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 0.00% | 0.00% |